A multi-center randomized proof-of-concept clinical trial applying [18F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease - Tzimopoulou, S; Cunningham, V J; Nichols, T E (J Alzheimers Dis, 2010)
, et al.